Kymriah approved for treatment of adults with relapsed or refractory large B-cell lymphoma
News
FDA grants Keytruda priority review
If approved by the FDA, this would mark the third indication for Keytruda in metastatic NSCLC in the United States based on OS data
MRC awards Bristol researcher £1.2M to investigate immune defence against microbes
Research will investigate neutrophil extracellular traps
FDA approval for Novartis’ melanoma combo
Tafinlar/Mekinist combo is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation
Clinical Researcher of the Year – The Americas: Winners announced!
The winners of the 2018 PharmaTimes Clinical Researcher of the Year competition were announced at an awards ceremony and gala dinner last night. It followed a day of fierce competition at the Regency Hyatt, in which 55 individual finalists and 16 teams battled it out for the coveted pharma in each of their respective categories.
US priority review for Sanofi, Regeneron’s cemiplimab
US regulators are undertaking a priority review of Sanofi and Regeneron’s cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC), or those with locally advanced CSCC who are not candidates for surgery.
AZ’ lung cancer drug Tagrisso backed for first-line use
European regulatory advisors are supporting approval of AstraZeneca’s lung cancer drug Tagrisso in the first-line setting.
Three medicines step closer to EU approval
Three medicines treating HIV, pain and cancer have been recommended for approval by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) at its latest meeting.
Final NICE nod for Keytruda in bladder cancer
MSD’s Keytruda has become the only immunotherapy to be funded by the NHS for the treatment of bladder cancer, following a final green light from cost regulators.
Clinical Researcher of the Year – The Americas: Last chance to book
The PharmaTimes Clinical Researcher of the Year – The Americas awards ceremony & gala dinner will take place in Washington DC on Sunday at the Hyatt Regency Crystal City, presented by UK actor Ryan Philpott, who has a host of TV credits to his name, including the nation’s all time favourite, Eastenders.
International Clinical Researcher of the Year – Less than 3 weeks to go – BOOK NOW
The countdown is on! With just under three weeks to go until the 2018 PharmaTimes International Clinical Researcher of the Year Awards Ceremony, companies are advised to book now to avoid disappointment.
PharmaTimes Media announces the launch of a brand new competition for sales professionals
With rigorous entry and judging standards, the all-new Sales Awards is designed to recognise the very best sales professionals in our industry today, while offering a crucial opportunity for learning and development.
Study finds widespread belief in “mythical” causes of cancer
Research led by University College London (UCL) and the University of Leeds, with support from a Cancer Research UK/Bupa Foundation Innovation Award, has revealed widespread public belief in “mythical causes” of cancer.
Vertex to test CF triple combo therapy in Phase III trials
Vertex Pharmaceuticals will begin testing a combination of VX-445, tezacaftor and ivacaftor as a potential treatment for people with cystic fibrosis (CF) in two Phase III studies.
AbbVie files risankizumab in the US
AbbVie has filed risankizumab in the US seeking approval for its use to treat moderate-to-severe plaque psoriasis.
